Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cell Biochemistry and Biophysics|May 28, 2026
1H-Indazole-3-Carboxylic Acid Derivatives as Disruptors of the Oncogenic MTDH-SND1 Protein-Protein Interaction: An In Silico-to-In Vitro StudyEmadeldin M Kamel, Sally Mostafa Khadrawy, Ahmed A Allam, et al.
Pharmacological Reports : PR|May 8, 2026
Recent advances in indole-thiazole hybrid scaffolds: synthesis, molecular hybridization, and pharmacological potentialDoaa A Abdelrheem, Sally Mostafa Khadrawy, Mohamed A M Ali, et al.
Pathology, Research and Practice|July 2, 2026
CBFβ-SMMHC in inv(16) AML: Fusion biology, RUNX1 dysregulation, and therapeutic targeting of a leukemogenic protein-protein interactionEmadeldin M Kamel, Sally Mostafa Khadrawy, Mohamed A M Ali, et al.
Discover Oncology|May 16, 2026
Disrupting the CBFβ-SMMHC-RUNX1 oncogenic protein-protein interaction in inv(16) AML: from fusion biology to targeted therapyEmadeldin M Kamel, Sally Mostafa Khadrawy, Mohamed A M Ali, et al.
Biochemical and Biophysical Research Communications|April 22, 2026
Discovery of [1,2,4]triazolo[1,5-a]pyrimidine-based disruptors of the Skp2-Cks1 protein-protein interaction through integrated computational and experimental analysisEmadeldin M Kamel, Sally Mostafa Khadrawy, Ahmed A Allam, et al.
Journal of Thrombosis and Thrombolysis|May 18, 2026
Protein-protein interaction disruption as a next-generation antithrombotic strategyEmadeldin M Kamel, Sally Mostafa Khadrawy, Mohamed A M Ali, et al.
Biochemical Pharmacology|April 8, 2026
Disrupting E3 ubiquitin ligase protein-protein interactions in cancer: chemical modalities, mechanisms, and therapeutic opportunitiesEmadeldin M Kamel, Sally Mostafa Khadrawy, Mohamed A M Ali, et al.
Neurochemistry International|April 10, 2026
Disrupting PQBP1-eEF2 protein-protein interaction: From synaptic translation to immunity and cancerEmadeldin M Kamel, Sally Mostafa Khadrawy, Mohamed A M Ali, et al.
Frontiers in Chemistry|April 23, 2026
Disrupting the KRAS-SOS1 protein-protein interaction: mechanistic rationale for pan-KRAS pathway suppression and combination therapyEmadeldin M Kamel, Sally Mostafa Khadrawy, Mohamed A M Ali, et al.
Pageof 3